Table 4 CAC results
From: Effect of insulin resistance on CAC scores in cancer survivors
Insulin Sensitive (N = 32) | IR - Prediabetic (N = 29) | IR - Diabetic (N = 29) | Total (N = 90) | Overall P-value | P-value Comparing DM vs. pre-DM | |
|---|---|---|---|---|---|---|
CAC-Agatson Score | 0.029a | 0.404a | ||||
Mean (SD) | 202.4 (520.6) | 183.9 (257.5) | 119.0 (202.4) | 169.5 (359.8) | ||
Median (Range) | 0.0 (0.0, 2316.0) | 74.0 (0.0, 977.0) | 39.0 (0.0, 969.0) | 27.5 (0.0, 2316.0) | ||
CAC-Agatson Score* | 0.005a | |||||
Mean (SD) | 81.6 (205.2) | 183.9 (257.5) | 119.0 (202.4) | 127.6 (224.4) | ||
Median (Range) | 0.0 (0.0, 876.0) | 74.0 (0.0, 977.0) | 39.0 (0.0, 969.0) | 23 (0.0, 977) | ||
CAC-Agatson Score (non-zero) | 0.388a | 0.148a | ||||
N | 15 | 23 | 24 | 62 | ||
Mean (SD) | 431.7 (702.9) | 231.8 (269.7) | 143.8 (214.9) | 246.1 (412.0) | ||
Median (Range) | 79.4 (2.0, 2316.0) | 158.0 (0.9, 977.0) | 69.5 (1.0, 969.0) | 94.5 (0.9, 2316.0) | ||
CAC-Agatson Score (non-zero)* | 0.321a | |||||
N | 13 | 23 | 24 | 60 | ||
Mean (SD) | 188.3 (282.8) | 231.8 (269.7) | 143.8 (214.9) | 187.2 (250.9) | ||
Median (Range) | 64.0 (2.0, 876.0) | 158.0 (0.9, 977.0) | 69.5 (1.0, 969.0) | 86.2 (0.9, 977.0) | ||
CAC Score (binary) | 0.005 | 0.999 | ||||
Non-zero | 15 (46.9%) | 23 (79.3%) | 24 (82.8%) | 62 (68.9%) | ||
Zero | 17 (53.1%) | 6 (20.7%) | 5 (17.2%) | 28 (31.1%) | ||
Mesa baseline %ile | 0.041 | 0.958 | ||||
Mean (SD) | 36.2 (41.2) | 56.3 (32.9) | 56.8 (31.9) | 49.3 (36.7) | ||
Median (Range) | 0.0 (0.0, 99.0) | 64.0 (0.0, 93.0) | 59.0 (0.0, 98.0) | 59.5 (0.0, 99.0) | ||
Mesa 10-Year CHD risk w/ CAC | < 0.001 | 0.045 | ||||
Mean (SD) | 5.3 (6.6) | 7.3 (5.1) | 11.0 (8.3) | 7.8 (7.1) | ||
Median (Range) | 2.1 (0.9, 27.6) | 5.5 (1.0, 18.8) | 6.6 (1.5, 35.1) | 5.5 (0.9, 35.1) | ||
Mesa 10-Year CHD risk w/o CAC | < 0.001 | < 0.001 | ||||
Mean (SD) | 4.2 (3.6) | 5.7 (3.5) | 10.9 (6.5) | 6.8 (5.5) | ||
Median (Range) | 2.4 (0.7, 14.4) | 4.9 (0.9, 15.4) | 9.0 (2.3, 24.6) | 5.3 (0.7, 24.6) |